US Patent Family Members and Approved Drugs for Norway Patent: 20025994
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Norway Patent: NO20025994
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Start Trial | 2020-06-16 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| ⤷ Start Trial | 2020-06-16 | insulin human | Novo Nordisk Inc. | NOVOLIN R |
| ⤷ Start Trial | 2020-06-16 | insulin human | Novo Nordisk Inc. | NOVOLIN R |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
